Amgen Inc. v. Sandoz Inc. (Fed. Cir. 2019)

Published date13 May 2019
Subject MatterPatents,Federal Rules of Civil Procedure,Biosimilars,BPCIA,Sandoz v Amgen
AuthorKevin E. Noonan
Law FirmMcDonnell Boehnen Hulbert & Berghoff LLP

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT